The treatment of ulcerative colitis with balsalazide sodium
- 1 September 1993
- journal article
- Published by Springer Nature in Inflammopharmacology
- Vol. 2 (3), 289-295
- https://doi.org/10.1007/bf02660619
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 monthsAlimentary Pharmacology & Therapeutics, 1992
- Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/dayAlimentary Pharmacology & Therapeutics, 1992
- Clinical tolerance to three 5‐aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazineAlimentary Pharmacology & Therapeutics, 1992
- Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double‐blind comparison with sulphasalazineAlimentary Pharmacology & Therapeutics, 1988
- Reversal with balsalazide of infertility caused by sulphsalazine.BMJ, 1984
- Studies of two novel sulfasalazine analogs, ipsalazide and balsalazideDigestive Diseases and Sciences, 1983
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)Gut, 1973
- The metabolism of salicylazosulphapyridine in ulcerative colitis: I The relationship between metabolites and the response to treatment in inpatientsGut, 1973